Also trades as: MDP.TO (TSX) · $vol 0M
MEDXF OTC
Medexus Pharmaceuticals Inc.
1W: -8.0%
1M: -12.6%
3M: -7.2%
YTD: +49.1%
1Y: +80.5%
3Y: +50.5%
5Y: +38.6%
$3.34
-0.11 (-3.22%)
Weekly Expected Move ±3.8%
$3
$3
$3
$3
$4
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$19M
-21.5% ▼
5Y CAGR: +30.2%
Capital Expenditures
$15M
-455.9% ▼
5Y CAGR: +7.1%
Free Cash Flow
$4M
-82.5% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$17M
-193.2% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$3M | $1M | -$213K | $2M | -$2M |
| Depreciation & Amort. | $6M | $6M | $6M | $7M | $10M |
| Stock-Based Comp. | $2M | $1M | $469K | $411K | $204K |
| Change in Working Capital | $5M | -$15M | $2M | $6M | $5M |
| Other Non-Cash Items | -$10M | $12M | $10M | $9M | $6M |
| Operating Cash Flow | -$1M | -$1M | $19M | $24M | $19M |
| — Investing Activities — | |||||
| Capital Expenditures | -$8M | -$362K | -$50K | -$183K | -$154K |
| Acquisitions (Net) | -$482K | -$1M | -$3M | -$3M | -$3M |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$10M | -$407K | -$216K | -$3M | -$14M |
| Investing Cash Flow | -$8M | -$2M | -$3M | -$6M | -$17M |
| — Financing Activities — | |||||
| Net Debt Issuance | $4M | $11M | -$26M | -$14M | -$17M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $947K | -$4M | -$4M | -$4M | -$2M |
| Financing Cash Flow | $663K | $6M | -$23M | $796K | -$19M |
| Net Change in Cash | -$9M | $3M | -$8M | $19M | -$17M |
| Cash End of Period | $10M | $13M | $5M | $24M | $7M |
| Free Cash Flow | -$9M | -$2M | $18M | $21M | $4M |